Marilyn Metcalf
GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Health Systems, Economic Evaluations, Quality of Life, Ethics in Clinical Research, Pharmaceutical industry and healthcare, Mental Health and Patient Involvement, Biomedical Ethics and Regulation
Most-Cited Works
- → Partnering With Patients in the Development and Lifecycle of Medicines: A Call for Action(2015)201 cited
- → Recommendations for benefit–risk assessment methodologies and visual representations(2016)67 cited
- → Living with tuberculosis: a qualitative study of patients’ experiences with disease and treatment(2022)46 cited
- → Patient Engagement at a Tipping Point—The Need for Cultural Change Across Patient, Sponsor, and Regulator Stakeholders: Insights From the DIA Conference, “Patient Engagement in Benefit Risk Assessment Throughout the Life Cycle of Medical Products”(2016)36 cited
- → Benefit–risk assessment in a post‐market setting: a case study integrating real‐life experience into benefit–risk methodology(2014)21 cited
- → Health care costs associated with chronic hepatitis B(1999)17 cited
- → Improving Information Exchange with Clinical Trial Participants: A Proposal for Industry(2017)9 cited
- → Recognizing that Evidence is Made, not Born(2018)4 cited
- → Contributors(2021)
- → Patient voice in clinical trial programs in industry(2021)